Increased Coverage for Hepatitis Monitors

Synovate Healthcare has announced the expansion of its Hepatitis B and Hepatitis C Global Therapy Monitors, the former to cover Poland, Greece and Turkey and the latter, currently US-only, to the five biggest European economies.

The agency says the Hepatitis B monitor, already the largest source of Hepatitis B prescribing data in the industry, is growing in line with client requirements. It already covers the US, China, South Korea, Taiwan, France, Germany, Italy and Spain.

The Hepatitis C Monitor was launched in the US in 2005 and will now cover France, Germany, Italy and Spain, with extension to the UK planned for 2007. Also next year, the US sample for both monitors will be significantly increased to provide further analysis options.

Rhoda Schmuecking, VP of the firm's Global Antiviral Therapy Monitors, comments: 'We are committed to investing in our Antiviral Therapy Monitors, and will continue to expand into other markets in order to meet our clients' need for global data.'

Synovate Healthcare is online at www.synovate.com/healthcare .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Synovate Healthcare UK
• All news